Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.

about

Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics.

P2860

Q38686555-A43D5836-33E4-4DE0-B20B-EFDBFA41DEA4 Q48277282-6626E264-3C11-4180-9537-09D64F66CB44

P2860

Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.

Item

http://www.wikidata.org/entity/Q43048911

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Sustained release of hydroxyca ...... d complex-DepoFoam technology.

@en

Sustained release of hydroxyca ...... d complex-DepoFoam technology.

@nl

type

Item

label

Sustained release of hydroxyca ...... d complex-DepoFoam technology.

@en

Sustained release of hydroxyca ...... d complex-DepoFoam technology.

@nl

prefLabel

Sustained release of hydroxyca ...... d complex-DepoFoam technology.

@en

Sustained release of hydroxyca ...... d complex-DepoFoam technology.

@nl

P1476

Sustained release of hydroxyca ...... id complex-DepoFoam technology

@en

P2093

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Tao Gong

http://www.w3.org/2001/XMLSchema#string

Yue Zhao

http://www.w3.org/2001/XMLSchema#string

Zhi-Rong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B

A lipid based depot (DepoFoam technology) for sustained release drug delivery.

Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.

Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats.

Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.

Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha.

Pharmacokinetics and efficacy of epidurally delivered sustained-release encapsulated morphine in dogs.

Safety assessment of encapsulated morphine delivered epidurally in a sustained-release multivesicular liposome preparation in dogs.

Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats.

The sustained granulopoietic effect of progenipoietin encapsulated in multivesicular liposomes.

P304

823-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03639040903520975

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xun Sun

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44642452

http://www.w3.org/2001/XMLSchema#string

P698

20515403

http://www.w3.org/2001/XMLSchema#string

Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.

about

P2860

P2860

Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698